UMC 0256 UMEDIC GROUP BERHAD | A Growing Company (Q3FY2023)
With the advancement of global medical technology and increased cross-border collaborations, the research, development, and manufacturing of high-end medical devices have been continuously improving. The application of new materials, sensors, artificial intelligence, and machine learning technologies has greatly facilitated the innovation and progress of high-end medical devices.
Just a few days ago, UMedic Group Berhad (UMC, 0256), a high-end medical equipment provider, released an impressive performance report, leading to a surge in the company's stock price.
Let's briefly comprehend this company’s background. Headquartered in Penang, UMC was established in 2002 and went public on the ACE Market in July 2022. The company is primarily engaged in the manufacturing, marketing, and after-sales services of various medical devices. It is worth mentioning that the company holds distribution rights for multiple international medical equipment companies, including GE Healthcare, Mindray, and Philips. In addition, UMC develops and manufactures its own brand of medical products, namely the HydroX series of prefilled humidifiers and the AirdroX series of asthma spacers.
To date, UMC has provided professional medical equipment and related services to thousands of customers, including public and private hospitals, healthcare service providers, hotels, airports, factories, and more, spanning over 30 countries worldwide. According to the 2022 annual report, UMC's customers are primarily from Malaysia, accounting for approximately 80.09% of the total revenue for the 2022 financial year. The Asia-Pacific region, including South Korea, India, Indonesia, Myanmar, the Philippines, Thailand, and Brunei, accounted for approximately 10.29% of the revenue. The remaining markets include Europe (6.84%), the United States (1.78%), the Middle East (0.47%), Oceania (0.35%), and Africa (0.18%).
Now, let's discuss UMC's latest performance in Q3FY2023.
Revenue Comparison (YoY +48.22%, QoQ -23.40%)
For the third quarter ending on April 30, 2023, the company achieved revenue of approximately RM9.59 million, an increase of approximately RM3.12 million or 48.22% compared to the same period last year, which was around RM6.47 million. This growth was primarily due to increased demand for medical devices from both public and private hospitals, as well as healthcare service providers. Additionally, the management stated that the revenue growth was also driven by increased sales of the company's HydroX and AirdroX products.
However, compared to the immediate preceding quarter, the company's revenue decreased by approximately RM2.93 million or 23.40%. This was due to a decline in sales of medical devices.
Net Profit Comparison (YoY +58.13%, QoQ -29.89%)
Benefiting from favorable foreign exchange rates and the growth in sales of medical devices and related products, the company's net profit increased by approximately RM0.75 million or 58.13% year-on-year, reaching around RM2.04 million.
As mentioned earlier, due to the decline in medical device sales this quarter, the company's net profit decreased by approximately RM0.87 million or 29.89% compared to the immediate preceding quarter.
Outlook
This year, the Malaysian Ministry of Health received a budget allocation of approximately RM36.30 billion through Budget 2023, which is higher than the previous year's allocation of around RM32.40 billion. This indicates that the government places significant emphasis on the domestic healthcare sector, which is good news for UMC. Therefore, the management remains confident about the company's future profit growth.
So, what are your thoughts on UMC, currently trading at a price-to-earnings ratio (P/E) of approximately 36.58?
#UMC
https://xifu.my/OpinionsComment.aspx?BID=B02284008PBAB0E0
Singapore Investment
-
-
-
-
-
-
Finance Investment Movement 5911 hours ago
-
-
-
-
-
-
Centurion Confirms REIT IPO16 hours ago
-
-
-
Bird Paradise – at a discount18 hours ago
-
-
-
-
-
-
-
-
Don’t Get Caught Buying This1 day ago
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Buying more6 days ago
-
-
-
-
-
-
-
I have Achieved Lean FIRE!!1 week ago
-
-
-
The Art of Being Patient1 week ago
-
-
-
-
-
2Q 2025 Investment Strategy Update2 weeks ago
-
Portfolio Summary for June 20252 weeks ago
-
-
Portfolio (June 30, 2025)2 weeks ago
-
Portfolio (June 30, 2025)2 weeks ago
-
-
-
Portfolio -- June 20252 weeks ago
-
June 2025 Updates2 weeks ago
-
-
Batisht crazy!2 weeks ago
-
-
Will SORA crash to 1 per cent?2 weeks ago
-
-
Hello world!2 weeks ago
-
-
-
Buying an overseas home for retirement3 weeks ago
-
8 tips for house moving3 weeks ago
-
-
-
-
-
-
-
-
-
-
-
-
Thakral - Gem life deal finally coming?1 month ago
-
-
-
Clarity1 month ago
-
The Trump Tariffs1 month ago
-
Selling HRnet and Fiverr2 months ago
-
-
-
-
Ignore the noise and be calm2 months ago
-
-
-
-
FAQ on Quantitative Investing Part 23 months ago
-
-
-
-
Crossing the 300k Mark [in a volatile period]3 months ago
-
-
-
-
-
-
-
-
ETF vs Mutual Fund: Which is Better?5 months ago
-
-
-
-
-
Arigato Everyone! A Decade of Blogging!6 months ago
-
Top 10 Highlights of 20246 months ago
-
-
-
Union Square Residences8 months ago
-
-
-
STI ETF9 months ago
-
-
-
Unibet Casino Bonus Codes 202410 months ago
-
-
-
-
-
Monthly IBKR Update – June 20241 year ago
-
-
-
-
-
-
-
-
-
Feb 2024 Expenditure1 year ago
-
-
-
-
-
-
-
Monthly Summary of November 20231 year ago
-
Migration of website1 year ago
-
-
-
-
-
-
Hello SP Group, I'm Back!2 years ago
-
-
-
A New Light2 years ago
-
-
-
-
-
2022 Thoughts, Hello 2023!2 years ago
-
Series of Defaults for Maple Finance2 years ago
-
Takeaways from “Sea Change”2 years ago
-
Greed is Coming Back2 years ago
-
-
-
-
-
-
-
-
What is Overemployment3 years ago
-
Terra Hill Condo (former Flynn Park)3 years ago
-
Alibaba VS Tencent: The Battle Royale3 years ago
-
-
-
-
-
-
-
-
-
-
-
-
-